Chlamydia Trachomatis
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
HologicClinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
Clinical Trials (1)
Total enrollment: 1,766 patients across 1 trials
NCT02795975HologicClinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
Start: Jun 2016Est. completion: Mar 20171,766 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space